Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

Image credit: Pharmacy_Karanov images - stock.adobe.com
SGLT2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

April 25th 2025

The findings highlight important differences between therapies in managing blood glucose, blood pressure, lipids, and adverse effects in this high-risk patient population.

Patient telling physician about his pain and health problems during visit to hospital. Young African-American man complaining about back ache while sitting on examination bed at the doctor's - Studio Romantic - stock.adobe.com.jpeg
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment

April 21st 2025

Center on Health Equity and Access
Health Equity & Access Weekly Roundup: April 21, 2025

April 21st 2025

Image credit: health care costs - Nuttapong punna
Cost-Effectiveness Analysis: CKD Screening, SGLT2 Inhibitors Can Reduce Kidney Failure Risk, Racial Disparities

April 18th 2025

Pharmacy online_evso - adobe.stock.com
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps

April 15th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Wordy cancer graphic
August 17th 2021

Cancer History May Elevate Kidney Failure Risk

Maggie L. Shaw
This new study from South Korea investigated if patients with cancer could be at potential greater risk of kidney failure and found connections with several cancer types.
kidney
August 13th 2021

Nephrotic Syndrome Linked With End-Stage Kidney Disease, Cardiovascular Issues

Jared Kaltwasser
Patients with nephrotic syndrome were far more likely than healthy controls to suffer end-stage kidney disease, particularly if they had focal segmental glomerulosclerosis or membranous nephropathy.
Lots of spilled pills
August 11th 2021

Potential Greater Mortality Risk From CKD Linked to Polypharmacy

Maggie L. Shaw
Major polypharmacy use was found to increase risk of mortality between 22% and 135% for American adults with chronic kidney disease (CKD) in this subanalysis of data from the REGARDS study.
Hypotension graphic
August 5th 2021

Orthostatic Hypotension Occurs Similarly Among CKD Patients With, Without DNP

Maggie L. Shaw
This recent study compared orthostatic hypotension outcomes among 2 patient populations, both with chronic kidney disease (CKD), who were or were not living with diabetic nephropathy (DNP).
kidney graphic
July 28th 2021

Longer CKD Duration Linked With Taste Dysfunction

Gianna Melillo
New research indicates an association between longer chronic kidney disease duration and taste dysfunction.
Image of doctor holding a kidney
July 25th 2021

Kidney Function Declines Along 4 Distinct Trajectories, Study Finds

Jared Kaltwasser
About 4 in 10 patients with chronic kidney disease will have “early rapid decline,” a trajectory more likely if the patient also has diabetes.
Hand holding the number 5
July 20th 2021

Panel Recommends 5 Reporting Requirements for Standardizing AKI Definition

Maggie L. Shaw
Inconsistent application and measure of the Kidney Disease Improving Global Outcomes definition of acute kidney injury (AKI) prompted this review, which used a measure of 75% agreement when defining consensus.
Neon-highlighted picture of kidneys
July 18th 2021

Acute Tubular Injury to Kidneys Likely Result of Severe COVID-19 Infection

Maggie L. Shaw
This new study from Japan investigated possible relationships between tubular injury, COVID-19 severity, and inflammatory markers with development of acute kidney injury.
DaVita, Former CEO Indicted for Market Collusion
July 15th 2021

DaVita, Former CEO Indicted for Market Collusion

Mary Caffrey
The dialysis company faces a $100M fine for each of 2 antitrust counts.
FDA approval stamp
July 15th 2021

FDA Approves Kerendia for Patients With CKD Associated With T2D

Lauren Massaro
Positive drug trial results suggest promising outcomes for adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
Exome Sequencing Reveals Genetic Origins of Some Kidney Disease Cases
July 12th 2021

Exome Sequencing Reveals Genetic Origins of Some Kidney Disease Cases

Jared Kaltwasser
Exome sequencing of patients with kidney disease and their families identified 17 different monogenetic causes of kidney disease.
Iron Therapy May Help Broader Group of Patients With Kidney Disease
July 10th 2021

Iron Therapy May Help Broader Group of Patients With Kidney Disease

Allison Inserro
A new study says that treating iron deficiency therapy may improve outcomes in patients with chronic kidney disease, even if they don’t have anemia.
pills and syringe
July 9th 2021

Review: SGLT2 Inhibitors Hold Promise in Improving Renal Outcomes

Jared Kaltwasser
Considerable evidence shows sodium-glucose co-transporter-2 inhibitors have cardioprotective benefits, but new research elucidates the ways in which the drugs can also have positive renal impacts.
CMS Targets Health Care Disparities in ESRD Rulemaking for 2022
July 2nd 2021

CMS Targets Health Care Disparities in ESRD Rulemaking for 2022

Allison Inserro
The proposed changes to the payment model for end stage renal disease (ESRD) would make it the first payment model under the CMS Innovation Center to directly address health equity by incentivizing increased rates of home dialysis and kidney transplants.
Jackson Williams, JD
June 27th 2021

Contributor: A More Nuanced View of Dialysis Providers “Gaming the Rules”

Jackson Williams, JD
The math is straightforward: The best way for employers and insurers to avoid paying for dialysis is to invest in preventive care.
Beyond Diabetes: SGLT2 Inhibitors in Heart Failure, CKD, and in Combination With GLP-1 RAs
June 27th 2021

Beyond Diabetes: SGLT2 Inhibitors in Heart Failure, CKD, and in Combination With GLP-1 RAs

Mary Caffrey
How therapeutic advances can address all 3 conditions was the topic of a symposium Friday during the 81st Scientific Sessions of the American Diabetes Association (ADA), “The Intersection of Diabetes, Heart Failure and Kidney Disease: Challenges and New Insights.”
Kidney icon
June 21st 2021

Potential Link Found Between Depression, Kidney Failure

Stephanie Loder
Adults with normal kidney function who have comorbid depression are more likely to experience a decline in kidney function and have mental and physical impairments from that decline.
Many Patients With ESKD Are Not Placed on Kidney Transplant Waitlist Despite Eligibility
June 17th 2021

Many Patients With ESKD Are Not Placed on Kidney Transplant Waitlist Despite Eligibility

Lauren Massaro
Eligible patients who are not waitlisted for kidney transplants lose profound opportunities and are subject to racial and socioeconomic disparities regarding waitlist placement, a study showed.
Neon kidney graphic
June 15th 2021

Dapagliflozin Shown to Be Safe, Effective in Patients With CKD

Larry Hanover
Dapagliflozin substantially slowed the progression of chronic kidney disease (CKD) in patients with immunoglobulin A nephropathy, according to a new study.
older man
June 9th 2021

CKD Linked With COVID-19 Severity in Older Patients

Jared Kaltwasser
Older patients with chronic kidney disease face higher risks of intensive care unit admission and in-hospital mortality if they contract COVID-19, a new report shows.
Lori Hartwell, CEO, Renal Support Network
June 6th 2021

Contributor: It’s Time for Medicare to Cover Oral Alternative Therapies for Iron Deficiency Anemia

Lori Hartwell
The founder of the Renal Support Network discusses why patients with chronic kidney disease want Congress to change Medicare policy to allow payment for oral treatments for anemia caused by iron deficiency.
Adults hands joined with child hands
June 2nd 2021

Longer Dialysis, Lack of Transplant Among Risk Factors for Vascular Disease in Children With ESRD

Jared Kaltwasser
About 5.4% of patients with end-stage renal disease (ESRD) who begin renal replacement therapy as children go on to have vascular events, and 4.1% of those patients die as a result of vascular events, though the real incidence rates are likely higher, according to new research.
image of kidneys
May 31st 2021

Penalties Under ESRD Incentive Program Did Not Improve Outpatient Dialysis Center Quality

Gianna Melillo
A new analysis reveals penalties levied under a CMS program to improve the quality of care at dialysis centers did not lead to significant change.
Illustration of doctor holding kidney
May 28th 2021

Study: Metformin Effective for Many Patients With T2D, Chronic Kidney Disease

Jared Kaltwasser
Some consider patients with type 2 diabetes (T2D) and chronic kidney disease poor candidates for metformin monotherapy due to the risk of lactic acidosis. However, new research finds patients who can tolerate the drug can gain similar benefits with or without kidney disease.
Changing Practice Patterns in CKD
May 26th 2021

Changing Practice Patterns in CKD

Robert Toto, MD
Closing out the discussion, an expert in chronic kidney disease (CKD) highlights how care for patients with CKD may change in the future based on data presented at AMCP.
Clinical and Humanistic Burden of IgA Nephropathy
May 26th 2021

Clinical and Humanistic Burden of IgA Nephropathy

Robert Toto, MD
Robert Toto, MD, provides his expert opinion regarding recent data from Forsythe, et al about the clinical and humanistic burden of IgA nephropathy.
IgA Nephropathy Data: US Incident Population
May 26th 2021

IgA Nephropathy Data: US Incident Population

Robert Toto, MD
An expert in chronic kidney disease (CKD) provides a recap of data, recently released at AMCP, around the estimate of the US incident population of IgA nephropathy.
brain scans
May 20th 2021

Population-Based Study Finds Link Between CKD, Dementia

Jared Kaltwasser
The new analysis suggests that dementia screenings might also include kidney function estimation.
Implications of Dapagliflozin Analysis in CKD
May 19th 2021

Implications of Dapagliflozin Analysis in CKD

Robert Toto, MD
An overview of the implications of the recent dapagliflozin data in chronic kidney disease (CKD) treatment to US clinicians and payers.
Results from DAPA-CKD: Time-to-Event and Cost Consequence
May 19th 2021

Results from DAPA-CKD: Time-to-Event and Cost Consequence

Robert Toto, MD
An expert in chronic kidney disease (CKD) discusses the importance of showing data at the 3-year mark for the DAPA-CKD study, released at AMCP.
<12345678910
...
13>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo